Quantitative Nanoproteomics for Protein Complexes (QNanoPX) Related to Estrogen Transcriptional Action*

We developed an integrated proteomics approach using a chemically functionalized gold nanoparticle (AuNP) as a novel probe for affinity purification to analyze a large protein complex in vivo. We then applied this approach to globally map the transcriptional activation complex of the estrogen response element (ERE). This approach was designated as quantitative nanoproteomics for protein complexes (QNanoPX). In this approach, the positive AuNP-ERE probes were functionalized with polyethylene glycol (PEG), and the consensus sequence of ERE and negative AuNP-PEG probes were functionalized with PEG without the ERE via a thiolated self-assembly monolayer technique. The AuNP-ERE probe had substantially low nonspecific binding and high solubility, which resulted in a 20-fold enrichment of the factor compared with gel beads. In addition, the surface-only binding allows the probe to capture a large protein complex without any restrictions due to pore size. The affinity purification method was combined with MS-based quantitative proteomics and statistical methods to reveal the components of the ERE complex in MCF-7 cells and to identify those components within the complex that were altered by the presence of 17β-estradiol (E2). Results indicated that a majority of proteins pulled down by the positive probe exhibited significant binding, and approximately one-half of the proteins, including estrogen receptor α (ERα), were slightly but significantly affected by a 24-h treatment with E2. Based on a combination of bioinformatics and pathway analysis, most of the affected proteins, however, appeared to be related to the transcriptional regulation of not only ERα but also c-Myc. Further confirmation indicated that E2 enhanced the ERE binding of c-Myc by 14-fold, indicating that c-Myc may play a major role, along with ERα, in E2-mediated transcription. Taken together, our results demonstrated a successful QNanoPX approach toward new pathway discovery and further revealed the importance of cross-interactions among transcription factors.

[1]  Jürgen Borlak,et al.  Transcription profiling of lung adenocarcinomas of c-myc-transgenic mice: Identification of the c-myc regulatory gene network , 2008, BMC Systems Biology.

[2]  A. Sandelin,et al.  Genome-Wide Identification of Estrogen Receptor α-Binding Sites in Mouse Liver , 2008 .

[3]  K. Hamad-Schifferli,et al.  Structure and function of nanoparticle–protein conjugates , 2008, Biomedical materials.

[4]  W. Ens,et al.  Characterization of IQGAP1-containing complexes in NK-like cells: evidence for Rac 2 and RACK1 association during homotypic adhesion. , 2007, Journal of proteome research.

[5]  G. Casari,et al.  A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway. , 2004, Nature cell biology.

[6]  Albert J R Heck,et al.  Triplex protein quantification based on stable isotope labeling by peptide dimethylation applied to cell and tissue lysates , 2008, Proteomics.

[7]  R. Kumar,et al.  Adaptive hypersensitivity to estrogen: mechanism for superiority of aromatase inhibitors over selective estrogen receptor modulators for breast cancer treatment and prevention. , 2003, Endocrine-related cancer.

[8]  Andrew G. Clark,et al.  Genomic Analyses of Transcription Factor Binding, Histone Acetylation, and Gene Expression Reveal Mechanistically Distinct Classes of Estrogen-Regulated Promoters , 2007, Molecular and Cellular Biology.

[9]  Ha-won Jeong,et al.  IQGAP1 Binds Rap1 and Modulates Its Activity* , 2004, Journal of Biological Chemistry.

[10]  S. Orkin,et al.  An Extended Transcriptional Network for Pluripotency of Embryonic Stem Cells , 2008, Cell.

[11]  J. M. Jameson,et al.  Quantitative Chemical Analysis , 1944, Nature.

[12]  J. Steitz,et al.  U2 snRNP binds intronless histone pre-mRNAs to facilitate U7-snRNP-dependent 3' end formation. , 2007, Molecular cell.

[13]  R. Deshaies,et al.  UBXD7 Binds Multiple Ubiquitin Ligases and Implicates p97 in HIF1α Turnover , 2008, Cell.

[14]  Y. Ouchi,et al.  Analysis of estrogen receptor α signaling complex at the plasma membrane , 2004 .

[15]  Ruedi Aebersold,et al.  Quantitative interaction proteomics using mass spectrometry , 2009, Nature Methods.

[16]  Adam A. Margolin,et al.  NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth , 2006, Proceedings of the National Academy of Sciences.

[17]  Gold nanoparticle-assisted protein enrichment and electroelution for biological samples containing low protein concentration--a prelude of gel electrophoresis. , 2006, Journal of proteome research.

[18]  F. Robert,et al.  Genome-wide computational prediction of transcriptional regulatory modules reveals new insights into human gene expression , 2006 .

[19]  S. Fields,et al.  Protein-protein interactions: methods for detection and analysis , 1995, Microbiological reviews.

[20]  Waltraud X. Schulze,et al.  A Novel Proteomic Screen for Peptide-Protein Interactions* , 2004, Journal of Biological Chemistry.

[21]  Shu-Hui Chen,et al.  Stable-isotope dimethyl labeling for quantitative proteomics. , 2003, Analytical chemistry.

[22]  R. Edwards,et al.  Identification of estrogen‐responsive proteins in MCF‐7 human breast cancer cells using label‐free quantitative proteomics , 2008, Proteomics.

[23]  J. Yates,et al.  Quantitative proteomic analysis of primary neurons reveals diverse changes in synaptic protein content in fmr1 knockout mice , 2008, Proceedings of the National Academy of Sciences.

[24]  J. Yates,et al.  Large-Scale Identification of c-MYC-Associated Proteins Using a Combined TAP/MudPIT Approach , 2007, Cell cycle.

[25]  John M Sedivy,et al.  A Large Scale Genetic Analysis of c-Myc-regulated Gene Expression Patterns* 210 , 2003, The Journal of Biological Chemistry.

[26]  B. A. Ballif,et al.  ATM and ATR Substrate Analysis Reveals Extensive Protein Networks Responsive to DNA Damage , 2007, Science.

[27]  John H. White,et al.  Selective Interaction of hsp90 with an Estrogen Receptor Ligand-binding Domain Containing a Point Mutation* , 1997, The Journal of Biological Chemistry.

[28]  V. Beneš,et al.  Transcriptome profiling of estrogen-regulated genes in human primary osteoblasts reveals an osteoblast-specific regulation of the insulin-like growth factor binding protein 4 gene. , 2008, Molecular endocrinology.

[29]  Andrea Califano,et al.  ChIP-on-chip significance analysis reveals large-scale binding and regulation by human transcription factor oncogenes , 2007, Proceedings of the National Academy of Sciences.

[30]  Jing Gao,et al.  Integration of Genome and Chromatin Structure with Gene Expression Profiles To Predict c-MYC Recognition Site Binding and Function , 2007, PLoS Comput. Biol..

[31]  S. L. Wong,et al.  Towards a proteome-scale map of the human protein–protein interaction network , 2005, Nature.

[32]  Clifford A. Meyer,et al.  Genome-wide analysis of estrogen receptor binding sites , 2006, Nature Genetics.

[33]  Zhiping Weng,et al.  Global mapping of c-Myc binding sites and target gene networks in human B cells , 2006, Proceedings of the National Academy of Sciences.

[34]  D. Garrod,et al.  Desmosome structure, composition and function. , 2008, Biochimica et biophysica acta.

[35]  M Angers,et al.  Structural and functional characterization of the human FMR1 promoter reveals similarities with the hnRNP-A2 promoter region. , 1997, Human molecular genetics.

[36]  Sandya Liyanarachchi,et al.  Combinatorial analysis of transcription factor partners reveals recruitment of c-MYC to estrogen receptor-alpha responsive promoters. , 2006, Molecular cell.

[37]  Andrea Cocito,et al.  Genomic targets of the human c-Myc protein. , 2003, Genes & development.

[38]  A. Sandelin,et al.  Genome-wide identification of estrogen receptor alpha-binding sites in mouse liver. , 2008, Molecular endocrinology.

[39]  Michael Q. Zhang,et al.  A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[40]  K. Basso,et al.  A systems biology approach to prediction of oncogenes and molecular perturbation targets in B-cell lymphomas , 2008, Molecular systems biology.

[41]  N. D. Clarke,et al.  Integration of External Signaling Pathways with the Core Transcriptional Network in Embryonic Stem Cells , 2008, Cell.

[42]  William Arbuthnot Sir Lane,et al.  Comprehensive Proteomic Analysis of Interphase and Mitotic 14-3-3-binding Proteins* , 2004, Journal of Biological Chemistry.

[43]  Jue-Liang Hsu,et al.  Dimethyl multiplexed labeling combined with microcolumn separation and MS analysis for time course study in proteomics , 2006, Electrophoresis.

[44]  Lan Huang,et al.  An Integrated Mass Spectrometry-based Proteomic Approach , 2006, Molecular & Cellular Proteomics.

[45]  M. Dai,et al.  Crosstalk between c‐Myc and ribosome in ribosomal biogenesis and cancer , 2008, Journal of cellular biochemistry.

[46]  B. Chait,et al.  The molecular architecture of the nuclear pore complex , 2007, Nature.

[47]  M. Cole,et al.  BAF53 Forms Distinct Nuclear Complexes and Functions as a Critical c-Myc-Interacting Nuclear Cofactor for Oncogenic Transformation , 2002, Molecular and Cellular Biology.

[48]  Javier A Menendez,et al.  Targeting fatty acid synthase in breast and endometrial cancer: An alternative to selective estrogen receptor modulators? , 2006, Endocrinology.

[49]  M. Catelli,et al.  The N-terminal adenosine triphosphate binding domain of Hsp90 is necessary and sufficient for interaction with estrogen receptor , 2001, Cell stress & chaperones.

[50]  Mike J. Mason,et al.  Role of the Murine Reprogramming Factors in the Induction of Pluripotency , 2009, Cell.

[51]  Sandya Liyanarachchi,et al.  Identifying estrogen receptor α target genes using integrated computational genomics and chromatin immunoprecipitation microarray , 2004 .

[52]  F. Stossi,et al.  Whole-Genome Cartography of Estrogen Receptor α Binding Sites , 2007, PLoS genetics.

[53]  M. Moran,et al.  Large-scale mapping of human protein–protein interactions by mass spectrometry , 2007, Molecular systems biology.

[54]  Kathryn A. O’Donnell,et al.  An integrated database of genes responsive to the Myc oncogenic transcription factor: identification of direct genomic targets , 2003, Genome Biology.

[55]  Itamar Willner,et al.  Biomolecule-nanoparticle hybrids as functional units for nanobiotechnology. , 2007, Chemical communications.

[56]  R. Aebersold,et al.  Identification of TFB5, a new component of general transcription and DNA repair factor IIH , 2004, Nature Genetics.

[57]  A. Chambery,et al.  Proteomic analysis of MCF‐7 breast cancer cell line exposed to mitogenic concentration of 17β‐estradiol , 2006, Proteomics.

[58]  Y. Ouchi,et al.  Analysis of estrogen receptor alpha signaling complex at the plasma membrane. , 2004, FEBS letters.

[59]  Chad A Mirkin,et al.  Gold nanoparticle probes for the detection of nucleic acid targets. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[60]  B. Katzenellenbogen,et al.  A repressive role for prohibitin in estrogen signaling. , 2008, Molecular endocrinology.

[61]  Wen-Ying Huang,et al.  Beyond quantitative proteomics: signal enhancement of the a1 ion as a mass tag for peptide sequencing using dimethyl labeling. , 2005, Journal of proteome research.

[62]  Jonghwan Kim,et al.  Global Identification of Myc Target Genes Reveals Its Direct Role in Mitochondrial Biogenesis and Its E-Box Usage In Vivo , 2008, PloS one.

[63]  A. Weisz,et al.  Identification of an estrogen response element upstream of the human c-fos gene that binds the estrogen receptor and the AP-1 transcription factor. , 1990, Nucleic acids research.